SecSonar.com

Revvity, Inc. (RVTY)

Revvity, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Revvity, Inc. (RVTY) is a Medical - Diagnostics & Research company based in US with a market capitalization of $11.6B. Revenue grew 3.7% year-over-year and the company generated $508.3M in free cash flow. This page tracks RVTY's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11K employees · IPO Jul 6, 1965

Valuation

Valuation & price

$93.97 · as of May 17, 2026 · -20.2% vs 52w high

44.0

P/E ratio

Latest-FY diluted EPS

1.59

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$117$100$83.36Jul 25Dec 25Jul 26Jul 7, 25$98.71Jul 9, 25$100.13Jul 11, 25$101.50Jul 15, 25$95.90Jul 17, 25$95.58Jul 21, 25$90.72Jul 23, 25$99.45Jul 25, 25$103.67Jul 29, 25$94.47Jul 31, 25$87.90Aug 4, 25$88.32Aug 6, 25$85.90Aug 11, 25$85.80Aug 13, 25$90.93Aug 15, 25$90.78Aug 19, 25$91.42Aug 21, 25$89.67Aug 25, 25$92.14Aug 27, 25$88.59Aug 29, 25$90.11Sep 3, 25$83.36Sep 5, 25$86.64Sep 9, 25$85.04Sep 11, 25$85.68Sep 16, 25$85.28Sep 18, 25$87.76Sep 22, 25$86.27Sep 24, 25$84.49Sep 26, 25$84.06Sep 30, 25$87.65Oct 2, 25$91.46Oct 6, 25$93.38Oct 8, 25$91.77Oct 10, 25$88.29Oct 14, 25$91.14Oct 16, 25$94.00Oct 21, 25$96.89Oct 23, 25$97.57Oct 27, 25$97.16Oct 29, 25$95.30Oct 31, 25$93.59Nov 4, 25$91.69Nov 6, 25$89.52Nov 10, 25$92.28Nov 12, 25$94.13Nov 14, 25$92.73Nov 18, 25$93.06Nov 20, 25$94.02Nov 25, 25$105.57Nov 28, 25$104.41Dec 2, 25$102.73Dec 4, 25$102.55Dec 8, 25$99.79Dec 10, 25$103.51Dec 12, 25$100.49Dec 16, 25$96.27Dec 18, 25$96.26Dec 22, 25$97.77Dec 24, 25$96.78Dec 29, 25$97.11Jan 2, 26$98.15Jan 6, 26$105.05Jan 8, 26$101.71Jan 12, 26$103.89Jan 14, 26$111.52Jan 16, 26$112.50Jan 21, 26$116.53Jan 23, 26$116.73Jan 27, 26$114.61Jan 29, 26$108.49Feb 2, 26$107.09Feb 4, 26$103.83Feb 9, 26$102.82Feb 11, 26$101.10Feb 13, 26$96.03Feb 18, 26$97.74Feb 20, 26$100.33Feb 24, 26$97.62Feb 26, 26$99.01Mar 2, 26$95.59Mar 4, 26$98.49Mar 6, 26$91.34Mar 10, 26$90.30Mar 12, 26$84.76Mar 17, 26$87.37Mar 19, 26$85.76Mar 23, 26$87.16Mar 25, 26$87.84Mar 27, 26$83.90Mar 31, 26$87.61Apr 2, 26$88.94Apr 7, 26$87.79Apr 9, 26$90.46Apr 13, 26$92.64Apr 15, 26$92.90Apr 17, 26$93.96Apr 22, 26$94.28Apr 24, 26$86.77Apr 28, 26$85.18Apr 30, 26$86.62May 4, 26$86.51May 6, 26$99.09May 8, 26$101.00May 12, 26$99.30May 14, 26$96.38May 18, 26$95.48May 20, 26$94.80May 22, 26$96.95May 28, 26$101.22Jun 1, 26$100.52Jun 3, 26$101.07Jun 5, 26$98.37Jun 9, 26$104.13Jun 11, 26$101.52Jun 15, 26$100.55Jun 17, 26$97.82Jun 22, 26$99.04Jun 24, 26$105.63Jun 26, 26$113.02Jul 2, 26$113.76
$82.2652-week range$117.75
Loading valuation history…

Fundamentals

Key fundamentals

$11.6B

Market cap

3.7%

Revenue growth (YoY)

53.1%

Gross margin

$508.3M

Free cash flow (USD)

$2.6B

Net debt

-7.8%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$2.1BFY 2017$2.3BFY 2018$2.8BFY 2019$2.9BFY 2020$3.8BFY 2021$3.8BFY 2022$3.3BFY 2023$2.8BFY 2024$2.8BFY 2025$2.9B
$2.1B$2.9B

Free cash flow by year

2016 → 2025

FY 2016$318.9MFY 2017$249.4MFY 2018$217.8MFY 2019$282.1MFY 2020$828.5MFY 2021$1.3BFY 2022$594.2MFY 2023$9.9MFY 2024$541.7MFY 2025$508.3M
$318.9M$508.3M

Gross margin by year

2021 → 2025

FY 202159.6%FY 202253.2%FY 202348.1%FY 202448.0%FY 202553.1%
59.6%53.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • 8-K eventBy-Laws AmendedMay 1, 2026Filing
  • Insider sellInsider Sell $7K · 10b5-1 PlanGonzales Anita · Vice President and CAO · $7.4KApr 22, 2026Filing

Questions

Frequently asked questions

What is Revvity, Inc.'s market cap?

Revvity, Inc. (RVTY) has a market capitalization of $11.6B.

What is RVTY's P/E ratio?

RVTY trades at a price-to-earnings ratio of 44.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is RVTY's price-to-book (P/B) ratio?

RVTY trades at 1.59 times book value per share.

Are insiders buying RVTY stock?

SEC Form 4 filings show no open-market insider buys at Revvity, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Medical - Diagnostics & Research

ICLR

ICON Public Limited Company

$10.5B

MEDP

Medpace Holdings, Inc.

$12.9B

CRL

Charles River Laboratories International, Inc.

$8.9B

QGEN

Qiagen N.V.

$7.6B

GH

Guardant Health, Inc.

$17.2B

SHC

Sotera Health Company

$4.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.